US 11,882,846 B2
Use of kefir peptide for improving or treating depressive behaviors and related diseases
Chuan-Mu Chen, Taichung (TW); and Hsiao-Ling Chen, Taichung (TW)
Assigned to NATIONAL CHUNG HSING UNIVERSITY, Taichung (TW)
Filed by National Chung Hsing University, Taichung (TW)
Filed on Nov. 26, 2021, as Appl. No. 17/535,829.
Claims priority of application No. 110115819 (TW), filed on Apr. 30, 2021.
Prior Publication US 2022/0346395 A1, Nov. 3, 2022
Int. Cl. A23C 9/127 (2006.01); A61P 25/24 (2006.01); A23C 9/13 (2006.01)
CPC A23C 9/127 (2013.01) [A23C 9/1307 (2013.01); A61P 25/24 (2018.01)] 6 Claims
OG exemplary drawing
 
1. A method for treating depression, comprising administering an effective amount of a composition to a subject in need thereof for enhancing an expression of brain-derived neurotrophic factor (BDNF) in hippocampal tissues of the subject and activating a BDNF/TrkB information channel, thereby improving or alleviating the depressive behaviors or symptoms of depression of the subject;
wherein the composition comprises a purified kefir peptide, and an amino acid sequence of the kefir peptide comprises a sequence of SEQ ID No: 2.